FDA panel recommends mRNA flu vaccine for older adults

The first flu shot of its kind is one step closer to being available to the public after a Food and Drug Administration (FDA) advisory panel voted Thursday to recommend Moderna’s mRNA-based vaccine for approval. The FDA’s independent vaccine advisers voted unanimously 9-0 that the benefits of Moderna’s amfluciva shot outweigh the risks in people…

Read More

What’s next for the weight loss drug maker

Shares of Danish biotech Zealand Pharma recently plunged after detailed data on its weight loss drug survodutide showed far higher patient dropout rates than leading treatments, prompting analysts to slash peak sales forecasts and rethink the company’s obesity strategy. But while the market’s enthusiasm for the drug has meaningfully cooled, investors are shifting focus to…

Read More

Andy Burnham wins Makerfield by-election

Andy Burnham has won a special election to the British parliament, clearing a path for him to challenge Prime Minister Keir Starmer for the party leadership. Burnham, Labour’s former Greater Manchester mayor, defeated the Reform U.K. party by more than 9,000 votes, taking nearly 55% of the vote, in the election in Makerfield, in north-west…

Read More

FDA panel gives nod to Moderna flu shot

Planned Parenthood {Beacon} Healthcare Health Care Presented by The Big Story FDA panel approves Moderna flu shot The FDA’s independent vaccine advisers voted unanimously 9-0 that the benefits of Moderna’s amfluciva shot outweigh the risks in people ages 50 to 64, as well as 65 years and older. The shot is… Source link

Read More